Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure

Published:2020-03 Issue:3 Volume:31 Page:369-376
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Alyamani M.,Li J.,Patel M.,Taylor S.,Nakamura F.,Berk M.,Przybycin C.,Posadas E.M.,Madan R.A.,Gulley J.L.,Rini B.,Garcia J.A.,Klein E.A.,Sharifi N.

Funder

National Cancer Institute

Prostate Cancer Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference27 articles.

1. Androgen signaling in prostate cancer;Dai;Cold Spring Harb Perspect Med,2017

2. Metastatic prostate cancer;Sartor;N Engl J Med,2018

3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

4. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

5. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer;Hussain;N Engl J Med,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of schizophrenia with the activities of the HPA and HPG axes and their interactions characterized by hair-based biomarkers;Psychoneuroendocrinology;2024-07

2. Sex differences orchestrated by androgens at single-cell resolution;Nature;2024-04-10

3. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04

4. Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer;The Oncologist;2023-05-03

5. Glucocorticoid regulation of cancer development and progression;Frontiers in Endocrinology;2023-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3